Form 4: Pediatrix Medical Group EVP Curtis Pickert Reports Share Transactions

Sentiment:

SEC Form 4


EVP and Chief Operating Officer of Pediatrix Medical Group, Curtis Pickert, reports acquisition and disposal of company shares, including a grant of restricted stock and a transfer to a family trust.

Summary

  • On June 1, 2024, Curtis Pickert, EVP and Chief Operating Officer of Pediatrix Medical Group, reported several transactions involving the company's common stock.
  • He acquired 68,400 shares of restricted stock as part of an annual equity award, with vesting occurring in installments over the next three years.
  • 751 shares were disposed of to cover tax obligations upon vesting.
  • Additionally, 2,332 shares were transferred to the Curtis B. Pickert Revocable Trust, where Pickert serves as trustee and his immediate family members are beneficiaries.
  • Following these transactions, Pickert directly owns 118,318 shares and indirectly owns 22,405 shares through the trust.

Sentiment

Score: 6

Explanation: The document is a standard regulatory filing detailing share transactions. It doesn't contain overtly positive or negative information, but the granting of restricted stock is generally a positive sign.

Positives

  • The grant of 68,400 restricted shares to a key executive suggests a long-term incentive and alignment of interests with the company's performance.

Future Outlook

The vesting schedule of the restricted shares indicates a multi-year commitment from the executive.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the actions of company executives regarding their holdings of company stock.

Related Party Transactions

  • The transfer of shares to the Curtis B. Pickert Revocable Trust, where the reporting person is the trustee and family members are beneficiaries, constitutes a related party transaction.

Stakeholder Impact

  • The transactions may have a minor impact on shareholders by slightly altering the ownership structure.
  • The vesting of restricted shares incentivizes the executive, potentially benefiting the company and its stakeholders.

Key Dates

DateDescription
06/01/2024Date of earliest transaction: acquisition of restricted shares, disposal of shares for taxes, and transfer of shares to a family trust.
06/01/202525% of the restricted shares will vest.
06/01/202625% of the restricted shares will vest.
06/01/202750% of the restricted shares will vest.
06/04/2024Date of signature by Attorney-in-Fact.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.